Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details Textual)

v3.10.0.1
Significant Accounting Policies (Details Textual)
Feb. 02, 2018
USD ($)
TG Therapeutics, Inc. [Member]  
Revenues $ 50,000